DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine On Wednesday evening, SII submitted a revised protocol for conducting the trials to the DCGI. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment